Health
First aerosolized inhaled COVID-19 vaccine proven safe in Phase-I clinical trials: developers – Global Times
The world’s first aerosolized inhaled adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV), jointed developed by CanSino…
CanSino’s one-shot COVID-19 vaccine
The world’s first aerosolized inhaled adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV), jointed developed by CanSino Biologics (CanSinoBIO) and researchers from the Institute of Military Medicine under the Academy…
Continue Reading
-
Noosa News20 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business23 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General13 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business22 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400